Assessment of the effects of telmisalthan and olmesartan on blood pressure, proteinuria, inflammation and oxidative stress in chronic kidney disease patients.
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2009
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Telmisartan (Primary)
- Indications Cardiovascular disorders; Essential hypertension; Hypertension
- Focus Pharmacodynamics
- 11 Sep 2009 New trial record